Literature DB >> 6296080

The relationship between incorporation of E-5-(2-Bromovinyl)-2'-deoxyuridine into herpes simplex virus type 1 DNA with virus infectivity and DNA integrity.

W R Mancini, E De Clercq, W H Prusoff.   

Abstract

E-5-(2-Bromovinyl)-2'-deoxyuridine (BrvdUrd) produced a dose-dependent shift in the density of herpes simplex virus type 1 (HSV-1) DNA at concentrations which yielded potent inhibition of virus replication in cultured Vero cells. Although the density of cellular DNA was not altered by these concentrations of BrvdUrd, incorporation of this analogue into cellular DNA of HSV-1-infected cells has been previously observed in this laboratory. The degree of inhibition correlated with the amount of BrvdUrd substituted for thymidine in HSV-1 DNA. BrvdUrd-substituted DNA was more labile as determined by a dose-dependent increase in single strand breaks when examined by centrifugation in alkaline sucrose gradients. Thus, the potent antiviral action of BrvdUrd observed in cell culture correlates not only with its incorporation into HSV-1 DNA but also with an altered stability of this DNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296080

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells.

Authors:  N K Ayisi; E De Clercq; R A Wall; H Hughes; S L Sacks
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 2.  Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.

Authors:  T Kulikowski
Journal:  Pharm World Sci       Date:  1994-04-15

3.  Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study.

Authors:  O P van Bijsterveld; P J Meurs; E de Clercq; P C Maudgal
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

4.  Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.

Authors:  C Desgranges; G Razaka; F Drouillet; H Bricaud; P Herdewijn; E De Clercq
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

5.  Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptides.

Authors:  S A Siegel; M J Otto; E De Clercq; W H Prusoff
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir.

Authors:  F M Hamzeh; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans.

Authors:  S Olofsson; I Sjöblom; K Hellstrand; D Shugar; C Clairmont; C Hirschberg
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 8.  Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides.

Authors:  Jerome Deval
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  The alternating conformation of analogues of poly[d(AT)].

Authors:  R S Reid; A L Stuart; S V Gupta; L J Latimer; B L Haug; J S Lee
Journal:  Nucleic Acids Res       Date:  1987-05-26       Impact factor: 16.971

10.  Oral BVDU treatment of varicella and zoster in children with cancer.

Authors:  Y Benoit; G Laureys; M J Delbeke; E De Clercq
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.